An open-label study of the safety and efficacy of topiramate for the prophylaxis of chronic migraine: extension study to CAPSS-276

Trial Profile

An open-label study of the safety and efficacy of topiramate for the prophylaxis of chronic migraine: extension study to CAPSS-276

Completed
Phase of Trial: Phase III

Latest Information Update: 21 May 2010

At a glance

  • Drugs Topiramate (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2010 Actual patient number added as 200 as reported by ClinicalTrials.gov.
    • 04 May 2010 Actual end date (Aug 2005) added as reported by ClinicalTrials.gov.
    • 04 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top